Terms: = Endocrine gland cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Treatment
68 results:
1. Identification of prognostic factors and construction of nomogram to predict cancer-specific survival for patients with ovarian granulosa cell tumors.
Zhang Y; Zhang Z; Ding X; Zhang K; Dai Y; Cheng W; Luo C
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2046. PubMed ID: 38507268
[TBL] [Abstract] [Full Text] [Related]
2. Multifactor assessment of ovarian cancer reveals immunologically interpretable molecular subtypes with distinct prognoses.
Guo Y; Li S; Li C; Wang L; Ning W
Front Immunol; 2023; 14():1326018. PubMed ID: 38143770
[TBL] [Abstract] [Full Text] [Related]
3. SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy.
Zheng X; Lin J; Xiong J; Guan Y; Lan B; Li Y; Gao X; Fei Z; Chen L; Chen L; Chen L; Chen G; Guo Z; Yi X; Cao W; Ai X; Zhou C; Li X; Zhao J; Yan X; Yu Q; Si L; Chen Y; Chen C
BMC Cancer; 2023 Jul; 23(1):686. PubMed ID: 37479966
[TBL] [Abstract] [Full Text] [Related]
4. Clinical features and therapeutic outcomes of GH/TSH cosecreting pituitary adenomas: experience of a single pituitary center.
Yu N; Duan L; Hu F; Yang S; Liu J; Chen M; Yao Y; Deng K; Feng F; Lian X; Mao X; Zhu H
Front Endocrinol (Lausanne); 2023; 14():1197244. PubMed ID: 37324275
[TBL] [Abstract] [Full Text] [Related]
5. The effects of Abemaciclib on cell cycle and apoptosis regulation in anaplastic thyroid cancer cells.
Abutorabi ES; Poursheikhani A; Kashani B; Shamsaiegahkani S; Haghpanah V; Bashash D; Mousavi SA; Momeny M; Ghaffari SH
Mol Biol Rep; 2023 May; 50(5):4073-4082. PubMed ID: 36877344
[TBL] [Abstract] [Full Text] [Related]
6. Exosomal RNAs in the development and treatment of pituitary adenomas.
Chang M; Jiang S; Guo X; Gao J; Liu P; Bao X; Feng M; Wang R
Front Endocrinol (Lausanne); 2023; 14():1142494. PubMed ID: 36875488
[TBL] [Abstract] [Full Text] [Related]
7. Sensitive electrochemical detection of polymorphisms in IL6 and TGFβ1 genes from ovarian cancer DNA patients using EcoRI and DNA hairpin-modified gold electrodes.
Meftah M; Habel A; Baachaoui S; Yaacoubi-Loueslati B; Raouafi N
Mikrochim Acta; 2022 Dec; 190(1):15. PubMed ID: 36479645
[TBL] [Abstract] [Full Text] [Related]
8. Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic cancer.
Goodwin CM; Waters AM; Klomp JE; Javaid S; Bryant KL; Stalnecker CA; Drizyte-Miller K; Papke B; Yang R; Amparo AM; Ozkan-Dagliyan I; Baldelli E; Calvert V; Pierobon M; Sorrentino JA; Beelen AP; Bublitz N; Lüthen M; Wood KC; Petricoin EF; Sers C; McRee AJ; Cox AD; Der CJ
Cancer Res; 2023 Jan; 83(1):141-157. PubMed ID: 36346366
[TBL] [Abstract] [Full Text] [Related]
9. Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors.
Zhang F; Zhang Q; Zhu J; Yao B; Ma C; Qiao N; He S; Ye Z; Wang Y; Han R; Feng J; Wang Y; Qin Z; Ma Z; Li K; Zhang Y; Tian S; Chen Z; Tan S; Wu Y; Ran P; Wang Y; Ding C; Zhao Y
Cell Res; 2022 Dec; 32(12):1047-1067. PubMed ID: 36307579
[TBL] [Abstract] [Full Text] [Related]
10. Genomic and TCR profiling data reveal the distinct molecular traits in epithelial ovarian cancer histotypes.
Zhu S; Zhang C; Cao D; Bai J; Yu S; Chen J; Wang J; Ren T; Yang J; Yu M; Xiao X; Gong Y; Guan Y; Li P; Yue Y; Yin R; Wang Y; An R; Lou G; Yuan J; Zhang G; Xia X; Yang L; Xiang Y
Oncogene; 2022 May; 41(22):3093-3103. PubMed ID: 35468938
[TBL] [Abstract] [Full Text] [Related]
11. Overexpression of miR-138-5p Sensitizes Taxol-Resistant Epithelial Ovarian cancer Cells through Targeting Cyclin-Dependent Kinase 6.
Liang M; Li Q; Shi S; Tian YN; Feng Y; Yang Y; Dong M; Zhang J; He J
Gynecol Obstet Invest; 2021; 86(6):533-541. PubMed ID: 34818258
[TBL] [Abstract] [Full Text] [Related]
12. miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian cancer Cells by Targeting CADM1.
Li C; Wang Y; Wang H; Wang B; Wang Y; Li N; Qin Y; Wang Y
Anal Cell Pathol (Amst); 2021; 2021():7407086. PubMed ID: 34395181
[TBL] [Abstract] [Full Text] [Related]
13. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway.
Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H
Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213
[TBL] [Abstract] [Full Text] [Related]
14. ΜiR-182-5p functions as a tumor suppressor to sensitize human ovarian cancer cells to cisplatin through direct targeting the cyclin dependent kinase 6 (cdk6).
Duan L; Yan Y; Wang G; Xing YL; Sun J; Wang LL
J BUON; 2020; 25(5):2279-2286. PubMed ID: 33277846
[TBL] [Abstract] [Full Text] [Related]
15. The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma.
Panzeri V; Manni I; Capone A; Naro C; Sacconi A; Di Agostino S; de Latouliere L; Montori A; Pilozzi E; Piaggio G; Capurso G; Sette C
Mol Oncol; 2021 Feb; 15(2):579-595. PubMed ID: 33159833
[TBL] [Abstract] [Full Text] [Related]
16. Patterns and predictors of cancer-related fatigue in ovarian and endometrial cancers: 1-year longitudinal study.
Poort H; de Rooij BH; Uno H; Weng S; Ezendam NPM; van de Poll-Franse L; Wright AA
Cancer; 2020 Aug; 126(15):3526-3533. PubMed ID: 32436610
[TBL] [Abstract] [Full Text] [Related]
17. Development of CDK2 and CDK5 Dual Degrader TMX-2172.
Teng M; Jiang J; He Z; Kwiatkowski NP; Donovan KA; Mills CE; Victor C; Hatcher JM; Fischer ES; Sorger PK; Zhang T; Gray NS
Angew Chem Int Ed Engl; 2020 Aug; 59(33):13865-13870. PubMed ID: 32415712
[TBL] [Abstract] [Full Text] [Related]
18. CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma.
Salvador-Barbero B; Álvarez-Fernández M; Zapatero-Solana E; El Bakkali A; Menéndez MDC; López-Casas PP; Di Domenico T; Xie T; VanArsdale T; Shields DJ; Hidalgo M; Malumbres M
Cancer Cell; 2020 Mar; 37(3):340-353.e6. PubMed ID: 32109375
[TBL] [Abstract] [Full Text] [Related]
19. Identification of cdk6 and RHOU in Serum Exosome as Biomarkers for the Invasiveness of Non-functioning Pituitary Adenoma.
Yu S; Wang XS; Cao KC; Bao XJ; Yu J
Chin Med Sci J; 2019 Sep; 34(3):168-176. PubMed ID: 31601299
[TBL] [Abstract] [Full Text] [Related]
20. Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian cancer Metastasis.
Kenny HA; Lal-Nag M; Shen M; Kara B; Nahotko DA; Wroblewski K; Fazal S; Chen S; Chiang CY; Chen YJ; Brimacombe KR; Marugan J; Ferrer M; Lengyel E
Mol Cancer Ther; 2020 Jan; 19(1):52-62. PubMed ID: 31562255
[TBL] [Abstract] [Full Text] [Related]
[Next]
